Sanofi-Aventis Nurtures Supplement Interest With Symbion Consumer Buy
This article was originally published in The Tan Sheet
Executive Summary
The dietary supplement market's attraction to pharmaceutical firms surfaces again with Sanofi-Aventis acquiring Australia's leading vitamin and mineral supplements company, Primary Health Care's Symbion Consumer business
You may also be interested in...
Sanofi-Aventis Acquisitions Could Double OTC Sales By 2014
French drug maker Sanofi-Aventis is establishing an OTC division and plans to double revenues from nonprescription drug products within five years
Sanofi-Aventis Acquisitions Could Double OTC Sales By 2014
French drug maker Sanofi-Aventis is establishing an OTC division and plans to double revenues from nonprescription drug products within five years
Sanofi-Aventis Acquisitions Could Double OTC Sales By 2014
French drug maker Sanofi-Aventis is establishing an OTC division and plans to double revenues from nonprescription drug products within five years